The Prosthetic Heart Valve Market is experiencing significant growth due to the rising prevalence of cardiovascular diseases, increasing elderly population, and advancements in medical technology.

MONTH AND TOMORROW IS HEART VALVE DISEASE AWARENESS DAY. SO RIGHT NOW I’M JOINED BY DOCTOR ARUN KUMAR REDDY WHO IS A CARDIOLOGIST AT UPMC. THANK YOU SO MUCH FOR JOINING US. REALLY APPRECIATE ...

The research team wanted to find out the clinical outcomes for patients aged between 50 to 70 years undergoing elective and urgent heart valve replacement at the Bristol Heart Institute (BHI) over ...

As part of National Heart Valve Disease Awareness Day area cardiologists want everyone to know the importance of this condition which occurs when the valves in the heart stop working properly and ...

Patients aged between 50 to 70 years with a mechanical heart valve replacement had better long-term survival compared to those with a biological valve, new research led by the University of Bristol ...

BURLINGTON, Vt. (WCAX) - Older Vermonters are finding a better quality of life thanks to a new heart valve procedure. Last year, Hazel Winter of Williston started feeling winded from simple tasks ...

A study led by the University of Bristol, Bristol, England, has found that mechanical heart valves provide better long-term survival than biological heart valves in patients aged 50-70 years.

Valentine's Day might now feel like a world away, but one of the holiday's best new arrivals in theaters is still holding on at the box office. Josh Ruben's Heart Eyes took audiences by surprise ...

Navi Mumbai: With heart valve disease on the rise in India, cardiac experts at Apollo Hospitals Navi Mumbai (AHNM) have highlighted the latest advancements in structural heart disease treatment.

We’re talking about TAVR, a minimally invasive procedure to fix a heart valve. Hartford HealthCare interventional cardiologist Dr. Robert Jumper with the Heart and Vascular Institute joined Good ...

An international task force has developed standards for tracking outcome measures of patients with heart valve disease, a condition which is expected to double in prevalence by 2040. The standards ...